The membrane topology of proton-pumping nicotinamide-nucleotide transhydrogenase from Escherichia coli was determined by site-specific chemical labeling. A His-tagged cysteine-free transhydrogenase was used to introduce unique cysteines in positions corresponding to potential membrane loops. The cysteines were reacted with fluorescent reagents, fluorescein 5-maleimide or 2-[(4-maleimidyl)anilino]naphthalene-6-sulfonic acid, in both intact cells and inside-out vesicles. Labeled transhydrogenase was purified with a small-scale procedure using a metal affinity resin, and the amount of labeling was measured as fluorescence on UV-illuminated acrylamide gels. The difference in labeling between intact cells and inside-out vesicles was used to discriminate between a periplasmic and a cytosolic location of the residues. The membrane region was found to be composed of 13 helices (four in the ␣-subunit and nine in the ␤-subunit), with the C terminus of the ␣-subunit and the N terminus of the ␤-subunit facing the cytosolic and periplasmic sides, respectively. These results differ from previous models with regard to both number of helices and the relative location and orientation of certain helices. This study constitutes the first in which all transmembrane segments of transhydrogenase have been experimentally determined and provides an explanation for the different topologies of the mitochondrial and E. coli transhydrogenases.
Nicotinamide-nucleotide transhydrogenases are integral membrane proteins that catalyze the reduction of NADP ϩ by NADH with a concomitant translocation of protons across the membrane, e.g. from the periplasm or intermembrane space to the cytosol or matrix in bacteria and mitochondria, respectively, according to the following: nH
Transhydrogenases are conformationally driven proton pumps in which binding and release of NADP(H) are thought to cause the structural changes allowing hydride transfer as well as proton translocation to occur (1) . It is generally concluded that the H ϩ
/H
Ϫ ratio of the transhydrogenase reaction is 1 (2) (3) (4) . At present, transhydrogenases from 12 different species have been cloned and/or sequenced that show an overall amino acid sequence identity of 23%. All transhydrogenases possess the same structural organization, regardless of primary sequence arrangement, with three major domains: two hydrophilic domains (domains I and III) comprising a 400-residue-long NAD(H)-binding domain and a 200-residue-long NADP(H)-binding domain, respectively, and domain II, containing a 360-residue-long hydrophobic domain that constitutes the membrane-spanning part of the enzyme (for reviews, see Refs. 4 and 5) . The hydrophilic domains have been shown to protrude into the cytosol or matrix in bacteria and mitochondria, respectively (6, 7) .
Escherichia coli transhydrogenase consists of two subunits, ␣ (510 residues) and ␤ (464 residues), assembled as an ␣ 2 ␤ 2 -tetramer. The membrane domain is composed of the 110 Cterminal residues of the ␣-subunit and the 260 N-terminal residues of the ␤-subunit and was shown to be directly involved in proton translocation via the only essential conserved protonatable residue within the membrane, His-␤91, located in the middle of a highly conserved transmembrane segment (8, 9) .
The membrane topology of transhydrogenases has previously been studied by predictions and experimental approaches resulting in different models. Early models were based on simple hydropathy analyses and suggested 14 transmembrane segments for the bovine enzyme and 11 transmembrane segments for the E. coli transhydrogenase (10, 11) . The E. coli enzyme was later refined to 12 helices (6) , and a similar model was also suggested for the Rhodospirillum rubrum enzyme (12, 13) . In more recent studies, two different models for E. coli have evolved. After applying several prediction methods to the bovine and E. coli sequences, Holmberg et al. (8) suggested a 10-helix model. On the basis of sulfhydryl labeling of native and engineered cysteines, Bragg and co-workers (14) suggested a slightly changed and refined 12-helix model. Due to incomplete or ambiguous results, various biochemical data such as proteolytic cleavage, antibody reactivity, and sulfhydryl labeling of the wild-type enzyme have not provided a generally accepted topology model, although they support each model to different extents. The models have proposed four ␣-helices in the ␣-subunit and six to eight helices in the ␤-subunit for the E. coli enzyme and 14 helices for the bovine enzyme, thus differing not only in number of ␣-helices, but also with respect to the relative positions and orientations of certain helices. To further investigate the mechanism of proton pumping by transhydrogenases, it is essential that a better knowledge of the structure of the membrane domain is achieved.
To clarify the topological ambiguities, the transmembrane segments and their topology were determined experimentally. A prediction of transhydrogenase membrane topology was made using information from the 10 known sequences for membrane-spanning transhydrogenases. The different models were tested by an experimental approach in which unique cysteines were introduced into potential loops of a cysteine-free E. coli transhydrogenase and reacted with membrane-impermeable thiol-specific reagents in oppositely oriented membrane preparations. By this procedure, it was possible to unambiguously determine the number of helices, their orientation, and also the beginning and end of some of the more conserved transmembrane segments. The proposed model differs from previous models and provides an explanation for the different topologies of the E. coli and mitochondrial transhydrogenases.
EXPERIMENTAL PROCEDURES
Plasmids and Strain-The pnt gene was introduced into the pGEM7Zf(ϩ) plasmid, resulting in the construct denoted pSA2 (15) . Alternatively, the pnt gene was introduced into the pUC13 plasmid, resulting in the construct pDC21 (16) . Protein expression was carried out with the E. coli K12 strain JM109 transformed with pSA2, or mutants thereof.
Mutagenesis-An N-terminal histidine hexamer tag was introduced into transhydrogenase by insertion of 21 bases, (CACCAT) 3 GGT, into the pDC21 construct by overlapping polymerase chain reaction as described (17) . The resulting construct, pNHis, contained six histidines and a glycine introduced between the first Met codon and the second Arg codon of the ␣-subunit. The Arg codon was changed to the more commonly used E. coli codon CGT (18) and a spontaneous T-to-G substitution occurred 38 bases upstream of the start codon. The His tag was transferred to pSA2 by replacing the HindIII/BstEII fragment of pSA2 with the corresponding fragment from pNHis, giving the construct pNH. The His tag was then transferred to a cysteine-free transhydrogenase construct, pCL (2) , by replacing the ApaI/SalI fragment of pCL with the corresponding fragment from pNH, giving the His-tagged and Cys-free construct pCLNH, which was used for mutagenesis in this work.
Mutagenesis of the cysteine mutants were performed with a two-step megaprimer polymerase chain reaction technique according to Landt et al. (19) . All mutants were verified by sequencing of the DNA fragments that had been manipulated by polymerase chain reaction and/or restriction digests. All DNA techniques used were standard procedures (20) .
Preparation of Cells and Vesicles for Labeling-Cells were grown for 16 h at 37°C and 185 rpm in LB medium supplemented with 0.1 mg/ml ampicillin and harvested by centrifugation at 3300 ϫ g for 5 min. The cells were resuspended in one-half the original volume of ice-cold 0.1 M Tris-HCl, 5 mM EDTA, 0.4 M sucrose, and 1 mM ␤-mercaptoethanol (pH 7.8) and incubated for 20 min on ice. After washing the cells once with buffer containing 50 mM Tris-HCl, 3 mM MgCl 2 , and 0.4 M sucrose (pH 7.5), they were resuspended in the same buffer supplemented with protease inhibitors (complete protease inhibitor mixture, EDTA-free; Roche Molecular Biochemicals) to an approximate concentration of A 600 nm ϭ 50. One-half of the permeabilized cells were labeled directly, and the second half were sonicated to produce inside-out vesicles (Branson microtip sonicator; 60 watts, 90 s of sonication time distributed as 5-s pulses during a total of 5 min). Unbroken cells and debris were removed after sonication by centrifugation at 3300 ϫ g for 5 min. Normally, Ͼ75% of the cells were transformed into vesicles.
Sulfhydryl Labeling with Fluorescein 5-Maleimide and 2-[(4Ј-Maleimidyl)
anilino]naphthalene-6-sulfonic Acid-Fluorescein 5-maleimide (from an 8 mM stock solution freshly prepared by diluting an 80 mM N,N-dimethylformamide stock solution with 50 mM sodium phosphate buffer (pH 7.8)) was added to cells and vesicles to a final concentration of 160 M, gently mixed, and incubated for 45 min on ice. 2-[(4Ј-Maleimidyl)anilino]naphthalene-6-sulfonic acid (MIANS) 1 (from a 100 mM stock solution in N,N-dimethylformamide) was added to cells and vesicles to a final concentration of 1 mM, gently mixed, and incubated on ice for 2 h. Unreacted reagents were quenched by the addition of a 50 -100-fold molar excess of cysteine.
Purification of His-tagged Transhydrogenase-To 325 l of labeled sample, 175 l of solubilization buffer (50 mM Tris-HCl, 2 M KCl, 64 mM imidazole, and 2 mg/ml lysozyme (pH 7.8)) was added. To avoid viscosity problems due to genomic DNA that interfered with the chromatographic procedure, DNase I was added to the whole-cell samples, which were also sonicated briefly (two to three pulses) to help to disrupt the cells. Triton X-100 was then added to 2% (w/v), and the membranes were solubilized by incubation for 20 min at room temperature with gentle mixing. Solubilized samples were spun at 38,000 ϫ g for 5 min to remove insoluble material. 25 l of Ni 2ϩ -nitrilotriacetic acid resin, equilibrated with wash buffer (20 mM Tris-HCl, 0.5 M KCl, 25 mM imidazole, and 0.1% (w/v) Brij 35 (pH 7.8)), was mixed with the supernatant (e.g. 450 l) in a filter spin tube (0.45 m; Millipore Corp.). After 20 min of gentle mixing at room temperature, the tubes were spun at 1000 ϫ g for 1 min and thereafter washed with 2 ϫ 250 l of wash buffer. Labeled transhydrogenase was eluted by incubating the resin in elution buffer (50 mM Tris, 0.2 M NaCl, 0.05% (w/v) dodecyl maltoside, and 300 mM imidazole (pH 7.2)) for 5 min before collecting the eluate by centrifugation.
Gel Electrophoresis and Analysis-Purified samples were dissolved in sample buffer at room temperature and subjected to SDS-polyacrylamide gel electrophoresis using 8% Tris/glycine gels (ready-made; Novex) according to Laemmli (21) . Labeled proteins were detected by illuminating the gels with UV light, and the fluorescence was recorded with a CCD camera equipped with appropriate filters. To achieve maximal fluorescence intensities, signals from fluorescein 5-maleimidelabeled samples were recorded before fixing the gel in 50% MeOH and 10% acetic acid; MIANS-labeled samples were recorded afterward. Gels were then stained with Coomassie Brilliant Blue R-250 and recorded with a CCD camera. The amount of protein and fluorescence intensities were analyzed with NIH Image1.62b7 (Freeware from the National Institutes of Health, Bethesda, MD).
Assay of Transhydrogenase Activity-Cytoplasmic inside-out membrane vesicles were prepared essentially as described before (2), but with 50 mM Tris and 1 mM EDTA (pH 7.8) as sonication and resuspension buffer. The activities of the mutant proteins were assayed by measuring the rate of reduction of 3-acetylpyridine NAD ϩ by NADPH catalyzed by the vesicle preparations as described previously (22) .
Protein Determination-Protein concentration in the membrane vesicles was determined by the method of Peterson (23) with bovine serum albumin as standard.
Predictions of Transmembrane Segments-The bovine, mouse, human, E. coli, R. rubrum, Entamoeba histolytica, Eimeria tenella, and Hemophilus influenzae transhydrogenase sequences were aligned (PileUp, GCG package, Genetics Computer Group, Inc., Madison, WI) and used as input in the programs TMAP (24) and PredictProtein (25) , which predicts transmembrane ␣-helices based on multiple alignments. The above sequences, together with the sequences for Caenorhabditis elegans and Cyanobacterium synechocystis, were also analyzed with TopPredConsensus, which is based on the program TopPredII (26), but uses multiple sequences to improve the accuracy of transmembrane ␣-helix predictions. 2 All programs were used with default settings. Chemicals-Fluorescein 5-maleimide and 2-[(4Ј-maleimidyl)anilino]naphthalene-6-sulfonic acid were obtained from Molecular Probes, Inc. Ni 2ϩ -nitrilotriacetic acid resin was obtained from QIAGEN Inc. All other chemicals were, unless otherwise specified, of analytical grade and purchased from commercial sources.
RESULTS
Prediction of Transmembrane Segments-Transhydrogenases from different sources were aligned and used to make consensus predictions of helical transmembrane segments by three different methods. The assumption that all transmembrane segments are ␣-helical was justified by the low number of predicted ␤-sheets that are too few to make a ␤-barrel structure (8) . The results from the consensus predictions are presented in Table I using helix numbering based on the original 14-␣-helix model of Yamaguchi et al. (10) and amino acid numbering corresponding to the E. coli sequence, which will be used throughout this paper. The output from TMAP and TopPredConsensus included both predictions of individual sequences as well as consensus predictions based on the multiple alignments. The differences between the predicted transmembrane ␣-helices of individual sequences when compared with the consensus prediction based on the multiple aligned sequences were generally small, i.e. minor displacements of some helices due to charged or polar amino acids and occasionally small gaps arising from the alignments. However, one exception was helix 5, which was not predicted in any of the consensus predictions, although it was found in the individual predictions of the mitochondrial (e.g. human, bovine, mouse, and C. elegans) transhydrogenases. Since only 4 of the 10 sequences contain the amino acids corresponding to this helix, it was given too low of a score in the consensus predictions and was therefore not assigned as a transmembrane ␣-helix. It is likely, though, that the mitochondrial transhydrogenases do contain helix 5 (see "Discussion"). Averaging the information derived from the different transhydrogenase sequences apparently did not conceal any information of the individual sequences, with the exception mentioned, but rather emphasized the common structural elements.
As shown in Fig. 1 , the three programs gave the same helical arrangement for the ␣-subunit, but three different arrangements for the ␤-subunit, differing not only with regard to number of helices, but also with regard to orientation and position of individual helices. In the ␣-subunit, five transmembrane segments were predicted by all methods with rather small differences. The first of these helices belongs to the ␤␣␤-nucleotide-binding fold in the hydrophilic domain and was therefore not included in the work or discussion of this paper. The remaining four helices corresponded to those previously predicted, approximately spanning amino acid sequences 402-421, 423-443, 451-471, and 480 -500 (Table I) , thus placing both termini on the cytosolic side.
The ␤-subunit, on the other hand, gave more ambiguous results. The prediction program PredictProtein assigned helices 6 -14 as transmembranous. However, considering the low scores of helices 7 and 13 (Table I) , i.e. the lengths of the proposed transmembrane segments were too short to form transmembrane ␣-helices, these helices were excluded, and a model with only seven transmembrane segments for the ␤-subunit was suggested (Fig. 1) . TMAP predicted seven helices for the ␤-subunit, excluding helix 8 and making one helix composed of parts of both helices 12 and 13 (Table I) . TopPredConsensus, on the other hand, predicted nine helices, 6 -14, as transmembranous for the ␤-subunit (Table I) .
Catalytic Activities of Single Cysteine Mutants-On the basis of the predictions and previous topological work, potential cytosolic and extracellular loops were identified. Using the cysteine-free construct pCLNH, individual residues in these loops were mutated to cysteines to give single cysteine mutants. The locations of selected positions are shown in Table II (cf. also Fig. 5 ). Topological studies of mutant proteins can be considered valid only if it can be shown that the mutants retain their native structure. An appropriate assay for native structure is retention of function. Thus, the ability of the single cysteine mutants to catalyze the reduction of 3-acetylpyrimidine NAD ϩ by NADPH was assayed. Activities of membrane vesicles from cells expressing the His-tagged single cysteine mutants were compared with those of the His-tagged cysteine-free transhydrogenase (CLNH transhydrogenase), which, in itself, retains ϳ50% activity compared with wild-type transhydrogenase. The properties of CLNH transhydrogenase have not been analyzed as thoroughly as those of the cysteine-free enzyme, previously shown to behave as the wild type, although with a somewhat lower catalytic rate (2). However, since His-tagged transhydrogenase exhibited approximately the same catalytic properties as the wild type, 3 it was assumed that the addition of a His tag to the cysteine-free enzyme did not alter its topological characteristics. Table II shows the activities of the single cysteine mutants. As was anticipated from the choice of mainly nonconserved residues for substitutions, most mutations had no or only a slight effect on the catalytic activities, i.e. the activities were at least 50% of the activity of the His-tagged cysteine-free transhydrogenase, and the mutants were thus considered as native in their fold. A substantially decreased activity was found only for the mutants ␤L24C, ␤A114C, and ␤S225C. However, it should be stressed that activities were not related to the amount of transhydrogenase, but to the total protein content of the vesicles in which transhydrogenase presumably represents a relatively constant fraction. A low activity may therefore be a consequence of a lowered amount of membrane-incorporated mutant protein due to decreased expression and/or decreased incorporation in the membrane due to erroneous folding. Proper incorporation was considered normal if the yields of the purified transhydrogenase mutants were Ͼ50% of the Histagged cysteine-free transhydrogenase. If this was not the case, incorporation was estimated directly by SDS-polyacrylamide gel electrophoresis of cytoplasmic vesicles. A deceased incorporation was indeed found with the ␤A114C mutant, which had a significantly lower incorporation (data not shown); the reason(s) for this effect was not analyzed further. In contrast, ␤L24C and ␤S225C also showed a lowered activity, but this was not due to decreased membrane incorporation (data not shown), but rather reflected the structural and/or functional importance of these fully conserved residues. However, the residual activity, although low, was taken as an indication of a correct overall topology of these mutants as well.
Purification of His-tagged Transhydrogenase-Expression and purification of single cysteine mutants were performed as described under "Experimental Procedures." A histidine hexamer was fused to the N terminus of the ␣-subunit of transhydrogenase to facilitate purification. The His tag was inserted by polymerase chain reaction/mutagenesis into the pSA2 con-3 J. Meuller, unpublished data. struct instead of using commercial His tag vectors to perturb the high expression level as little as possible. The fusion construct was readily expressed, and the His tag was accessible as shown by binding to Ni 2ϩ -nitrilotriacetic acid resin. This system allowed us, starting from crude cell lysates, to purify ϳ4 mg of mutant protein/liter of culture with a purity of Ͼ75% as judged from SDS-polyacrylamide gels (Fig. 2) . The high degree of purity achieved with this simple purification method enabled us to detect even minor amounts of labeled transhydrogenase that otherwise would have been obscured by the presence of impurities. Solubilization of membrane proteins was performed with Triton X-100 instead of the previously used cholate/deoxycholate (27) . This gave a yield of solubilized transhydrogenase that was higher, although it also resulted in a slightly less active state after purification (data not shown). As the purification only served to clean up already assayed samples, this was not considered a problem for this study and was therefore not analyzed further.
Labeling with Sulfhydryl Reagents-Single cysteine mutants were labeled with membrane-impermeable thiol-reacting fluorescent reagents in intact membranes of opposite orientations. Two different reagents were used: fluorescein 5-maleimide, which at neutral pH is a dianion and membrane-impermeable, and the monoanionic and more hydrophobic reagent MIANS, which, although still membrane-impermeable, should be able to penetrate farther into hydrophobic environments (28 -30) . All mutants were assayed with fluorescein maleimide, but some of them were resistant to modification probably due to a limited exposure of these thiols to the solvent. To achieve topology information for these mutants, MIANS was used at high concentrations and prolonged incubation times (see "Experimental Procedures"). Cysteine residues in periplasmic loops should be accessible to membrane-impermeable reagents only in intact cells, whereas cysteine residues in cytosolic loops should be accessible only in inside-out vesicles. By comparing the extent of modification in inside-out vesicles with that obtained in intact cells, the sidedness of each reactive cysteine could be determined. The results of this approach are valid only if it can be shown that the modifying reaction is thiol-specific, that the membranes are impermeable to the reagents, and that the membrane preparations have opposite orientations. Fig. 3 shows examples of single cysteine mutants of the ␣-and ␤-subunits labeled with fluorescein 5-maleimide in intact cells and inside-out vesicles, purified, and separated on an SDS-polyacrylamide gel. Fig. 3A shows the samples when illuminated by UV light, and Fig. 3B shows the samples after Coomassie staining. The thiol specificity of the reagent is demonstrated by the absence of fluorescent signal in the ␣-subunit of the ␤A262C and ␤A114C mutants and by the absence of fluorescent signal in the ␤-subunit of the ␣Q474C mutant. To demonstrate that the membrane preparations had correct orientations and that both preparations were readily labeled, we used mutants ␤A262C and ␤A114C. The close proximity of ␤A262C to a cytosolic trypsin site, Arg-␤265 (6), shows that this position is on the cytosolic side. Likewise, the close proximity of ␤A114C to residues ␤116 and 117 (bovine residues 690 and 691), the corresponding position where bovine transhydrogenase in mitoplasts is cleaved by proteinase K (31), shows that this position is on the periplasmic side. As shown in Fig. 3 , the ␤A262C mutant was labeled to a greater extent in inside-out vesicles than in intact cells. For the ␤A114C mutant, the opposite behavior was observed. These results demonstrate that the membrane preparations have the assumed orientation and 
a ND, not determined. that cysteines located in periplasmic loops are accessible only in intact cells and not in vesicle preparations, whereas the opposite is valid for cytosolic locations. The preferential labeling of ␤A262C and ␤A114C further showed that the membranes were impermeable under the conditions stated under "Experimental Procedures." Fig. 4 shows ␤S30C as an example of a single cysteine mutant labeled with MIANS in intact cells and inside-out vesicles, purified, and separated on an SDS-polyacrylamide gel. The first two lanes show the samples when illuminated by UV light, and the last two lanes show the samples after Coomassie staining. The characteristics of MIANS labeling with regard to thiol specificity and membrane permeability were similar to those of fluorescein maleimide labeling (data not shown), although the high concentration of reagent and N,N-dimethylformamide (1%) and the prolonged incubation time, as compared with fluorescein maleimide labeling, gave rise to some nonspecificity and leakage across the membrane. The major part of the nonspecificity seemed to be due to MIANS itself, which, like fluorescein 5-maleimide, reacts with free thiols through a maleimide, since nonspecificity was observed also under conditions similar to those used for fluorescein maleimide labeling. However, interpretation of MIANS-labeled samples was not complicated by the nonspecificity due to the high purity of the analyzed samples, and the conditions for labeling were not optimized further.
Results from the labeling studies are summarized in Tables  III and IV . To correct for different amounts of protein and for experimental deviations from one occasion to another, all fluorescent intensities were correlated to the amount of protein by dividing the fluorescence intensity by the corresponding intensity of the Coomassie-stained gels. Furthermore, for each mutant, both intact cells and inside-out vesicles were always made in parallel and run on the same polyacrylamide gel. The corrected fluorescent signals from vesicle preparations were then divided by the corresponding cell preparations to give a ratio describing which kind of preparation was preferably labeled and thus the location of each mutant. The ratios in Tables III  and IV were interpreted without limitations of any upper and lower values, i.e. a value Ͼ1 indicates a cytosolic location, and a value Ͻ1 indicates a periplasmic location. Sidedness was determined for 22 of the 28 mutants with a typical 5-20-fold preference of labeling of one side of the membrane over the other.
Some mutants were not labeled with either of the two reagents. Although the absence of modification should not be viewed as evidence for location, the unreactive nature of these residues was consistent with data from labeled residues that define them as being buried inside the membrane core. In addition, residues resistant to modification by fluorescein maleimide or MIANS, e.g. ␤S92C, ␤A142C, ␤L173C, ␤S225C, and ␤S250C, were labeled (data not shown) with the hydrophobic reagent IANBD, which is membrane-permeable (28) . No information about the sidedness of the IANBD-reactive residues could be drawn, although their sensitivity to this agent further supports a membranous location of these residues. Transhydrogenase Topology-The proposed model for the membrane topology of E. coli is shown in Fig. 5 (cf. Table I ). In the ␣-subunit, Glu-␣423, Ala-␣448, Gln-␣474, Thr-␣498, and Gln-␣501 were changed to cysteines and labeled with fluorescein maleimide. ␣E423C and ␣Q474C were preferably labeled in intact cells and are thus exposed to the periplasmic side ( Fig.  3 and Table III) . ␣A448C and ␣Q501C, on the other hand, were preferably labeled in inside-out vesicle preparations and therefore are exposed to the cytosolic side (Table III) . ␣T498C was not labeled at all by fluorescein maleimide, but was shown to be cytosolic by MIANS labeling (Tables III and IV) . It was shown previously that the ␣-subunit is cleaved by trypsin in inside-out vesicles at Lys-␣390 to yield a soluble domain and a membrane domain (6) . A fair assumption considering the hydrophilicity of the residues preceding this cleavage site is that the membrane region starts at Tyr-␣403 after the two positive charges Arg-␣401 and Lys-␣402. The first helix should thus extend from Tyr-␣403 to Lys-␣422, but possibly to Pro-␣421 since Glu-␣423 reacts readily with fluorescein maleimide. This gives a stretch of 19 -20 residues, which is enough to span the membrane core considering that the presence of a proline breaks the helical structure and elongates the transmembrane segment. The location of the two consecutive helices was further restricted by the labeling of ␣A448C and ␣Q474C, which, together with the hydrophilic environment around ␣A448C, gave a well defined topology with helix 2 extending from Phe-␣424 -Val-␣445 and helix 3 from Pro-␣452-Ile-␣472. The last helix of the ␣-subunit is not as well defined, but is made up of residues between labeled ␣Q474C and ␣Q501C. Labeling of ␣T498C by MIANS (but not by fluorescein maleimide) indicated that this residue is somewhat buried, probably in the membrane interface, which further restricts the topology of helix 4. The C terminus of the ␣-subunit is cytosolic since the remaining residues of the ␣-subunit are very hydrophilic and too few to traverse the membrane.
In the ␤-subunit, 24 different single cysteine mutants were used to determine the topology. Starting from the N terminus, ␤S2C was labeled to a greater extent in intact cells than in vesicles (Table III) . This shows that the N terminus of the ␤-subunit faces the periplasmic space, and not the cytosol as previously suggested (cf. "Discussion"), thus giving this subunit an asymmetric distribution of its termini. Labeling experiments performed on intact and solubilized vesicles gave similar results (data not shown).
␤L24C and ␤S30C were labeled with MIANS, but not with fluorescein maleimide, suggesting that these positions are partly buried (Tables III and IV) . ␤L24C showed only a slight preference for cytosolic labeling, and in addition, the overall reactivity of ␤L24C was very low compared with ␤S30C (data not shown), indicating that ␤L24C is buried in the membrane, whereas ␤S30C might be more exposed. The preferential labeling of ␤S30C in vesicles over intact cells indicated a cytosolic location. Thus, the N terminus of the ␤-subunit is indeed transmembranous, adding helix 6, presumably Gly-␤4 -Ser-␤25, to the previous transhydrogenase topology. Indeed, helix 6 is among the strongest predicted transmembrane helices in this work (Table I) , but was rejected in previous work on either theoretical premises or after experimental determination. Helix 6 is followed by a hydrophilic cytosolic loop containing two positively charged residues, Lys-␤26 and Arg-␤31, which probably act in defining the extent of the loop region.
Helix 7 ends with a short periplasmic loop containing ␤T54C, which was labeled with fluorescein maleimide in intact cells, but not in vesicles (Table III) . Helix 7 thus likely extends from Gln-␤32 to Pro-␤52. Helix 8 is defined by ␤T54C and ␤T81C, but extends probably only from Asn-␤56 to Ala-␤75, thus placing the two lysines at positions ␤76 and ␤77 as anchors outside the membrane. ␤T81C and ␤S105C were labeled in vesicles and intact cells, respectively (Table III) . ␤E85C was labeled with fluorescein maleimide, slightly in favor of a cytosolic location (Table III) , but the overall reactivity of the mutant was very low (data not shown), making it more likely that this residue resides in the membrane interface or within the membrane. Considering that ␤S105C was readily labeled with fluorescein maleimide and that ϳ21 residues are needed to span the membrane, these observations suggest that helix 9 should extend from residues ␤84 Ϯ 1 to ␤104 Ϯ 1. The boundaries of helix 10 are more uncertain since they are defined in these experiments by a stretch of 42 amino acids between ␤A114C and ␤L157C, which are labeled preferentially in intact cells and inside-out vesicles, respectively. A fair assumption, supported by the predictions, is that helix 10 is composed of the residues between Glu-␤124 Ϯ 1 and Gly-␤144 since neighboring residues are very variable and predominantly hydrophilic. Again, this puts a positive charge just inside the membrane bilayer on the cytosolic side of a helix. The resistance of ␤A142C to modification by either fluorescein maleimide or MIANS (Tables III and IV) indeed suggests that this residue is located in the membrane.
Helix 11 is included in the 25 residues between ␤L157C and ␤S183C, which were determined to be located in a cytosolic and a periplasmic loop, respectively (Table III) . ␤L173C was not labeled with either fluorescein maleimide (Table III) or MIANS (Table IV) , which agrees with a membrane-buried location. Helix 12 is included in the 24 residues defined by ␤S183C and ␤S208C (Table III) . ␤S208C and ␤M214C were both labeled preferentially in inside-out vesicles, thus supporting a cytosolic location, whereas labeling of ␤S237C and ␤D239C indicated a periplasmic location, in the loop between helices 13 and 14 (Table III) . Together with ␤A262C, which was labeled preferentially in inside-out vesicles (Table III) , these residues restrict the extension of the last two helices, which, together with helix 9, are the most conserved ones. The behavior of ␤C260C and ␤V216C, which were labeled with MIANS in inside-out vesicles (Table IV) , but not with fluorescein maleimide (Table III) , suggests a slightly buried location of these residues and further restricts the extensions of helices 13 and 14. Our data thus indicate that helix 13 should extend from Val-␤216 to Leu-␤236 and helix 14 from Leu-␤240 to Cys-␤260.
DISCUSSION
The membrane topology of E. coli transhydrogenase was determined by modification of engineered cysteines. Thiol modification has become a powerful technique in protein biochem- 
NF -a P, periplasmic location; C, cytosolic location; -, no location assigned; NF, no fluorescence observed. b Very weak fluorescence signal.
TABLE IV Labeling of single cysteine mutants with MIANS
Values were derived by dividing the fluorescence intensity (I F ) per amount (I C ) of labeled subunit for vesicle preparations, (I F /I C ) ves , by the corresponding value from cell preparations, (I F /I C ) cell . Values are averages of two or more determinations.
13 C a C, cytosolic location; -, no position assigned; NF, no fluorescence observed.
istry allowing the specific removal or insertion of cysteines. By introducing and modifying cysteines in the membrane protein Lac permease, Kaback and co-workers (for an extensive review, see Ref. 32) identified the catalytically important residues and defined a structural relationship of the membrane helices containing them. The movement of these transmembrane helices relative to each other and changes in accessibility of certain residues upon binding of substrate were also demonstrated. Furthermore, the helical structure of a transmembrane segment was shown using quenching of an attached EPR probe, and distances within the protein were measured by attached EPR probes and an engineered metal-binding site (32) . Thus, modification of cysteines constitutes an attractive indirect approach to structural and dynamic studies of membrane proteins, which are difficult to crystallize.
For membrane topological studies, thiol modification has also become an alternative to fusion of marker proteins, epitope mapping, etc. The advantage of using introduced cysteines is that the native fold is less perturbed compared with when large deletions/insertions are created and that reagents, which are available in a large variety of size and polarity, are easy to change to fit the experimental approach. The topologies of the membrane-spanning proteins MotA (29), Tn10-TetA (33), and human P-glycoprotein (34), among others, were determined by different approaches exploiting the specificity of some reagents for thiols. A drawback with some of these approaches is that interpretations are made on the basis of absence of signals, e.g. failure of a membrane-impermeable thiol reagent to block the reaction of another reagent with cysteines. In this report, results are based solely on positive signals that were obtained by using two oppositely oriented membrane preparations for each mutant, thus avoiding the problem of different reactivity of different reagents and/or positions.
The membrane topology of E. coli transhydrogenase as determined in this study includes 13 helices, four in the ␣-subunit and nine in the ␤-subunit. Both C termini are located cytosolically, as is the ␣-subunit N terminus, whereas the ␤-subunit N terminus is located on the periplasmic side. The distribution of positive charges follows the positive inside rule (35) , with basic residues predominantly located on the cytosolic side (⌬15) and acidic residues more evenly spread (⌬1) (Fig. 5) . The proposed transmembrane helices contain between 19 and 22 amino acids, the average length being that required to span the nonpolar region of the membrane. Thus, even considering the uncertainty about the proposed lengths, especially for helices 4, 10, and 11, this means that the helices should have a rather small tilt relative to the membrane plane. Furthermore, the predicted loops on the periplasmic side are short (six residues or less), except for the highly variable loop between helixes 9 and 10, which is 20 residues long, indicating that the enzyme does not protrude from the membrane surface at all on the periplasmic side. Thus, there are no obvious peripheral structural elements that can have regulatory effects on the entry and exit points of the proton pathway. The loops on the cytosolic side are generally longer, and in addition, the two large hydrophilic domains (domains I and III) face this side. Surprisingly, most of the cytosolically located residues are very accessible to such large molecules as fluorescein maleimide and MIANS, indicating a rather loose binding of domains I and III to the membrane surface, at least under the conditions used in this study. The binding of NADP(H) to transhydrogenase is known to cause conformational changes (6) , and possibly these act to move at least domain III in closer contact with the membrane and the proton channel. This view is supported by the resistance of ␤M214C to modification by fluorescein maleimide if labeling of the vesicles is performed in the presence of NADP(H) (data not shown).
The 13-helix model presented agrees well with most experimental data previously reported. Proteinase K cleaved bovine transhydrogenase in mitoplasts between residues 690 and 691, suggesting that these residues are exposed on the cytosolic side (31) . Likewise, trypsin cleaved bovine transhydrogenase between residues 602 and 603, suggesting that these residues are exposed on the matrix side (36) . The corresponding residues in E. coli transhydrogenase (positions ␤116 and ␤117 and positions ␤31 and ␤32) are indeed proposed to be within the periplasmic loop connecting helices 9 and 10 and within the cytoplasmic loop connecting helices 6 and 7, respectively (Fig.  5) . Modification of Cys-626 with N-ethylmaleimide in the bovine enzyme suggested a cytosolic location (36) , which agrees with a location of the corresponding E. coli residue (position ␤55) in the periplasmic loop connecting helices 7 and 8. Antibodies raised against a peptide corresponding to positions 540 -554 of the bovine transhydrogenase bound to the enzyme in submitochondrial particles, but not in mitoplasts, suggesting that these residues are exposed to the matrix (7). Since the corresponding E. coli residues are the last six residues of the ␣-subunit and part of the gap between the ␣-and ␤-subunits, this agrees with the C terminus of the ␣-subunit being located on the cytosolic side.
Bragg and co-workers (14) proposed a model of the membrane topology of the ␤-subunit of the E. coli transhydrogenase. By sulfhydryl labeling using maleimidylpropionylbiocytin and MIANS, they concluded that ␤S2C, ␤S30C, ␤C147C, and ␤S208C were located on the cytoplasmic side of the membrane and that ␤S171C and ␤C260C were located in the membrane. These results are, with the exception of ␤S2C, in agreement with our data. However, in their experiments, ␤S2C was located on the cytosolic side, which is in contradiction to our model, where ␤S2C is on the periplasmic side. The location of this residue on the same side of the membrane as ␤S30C excludes helix 6. In their experiments using maleimidylpropionylbiocytin, a rather weak modification of ␤S2C was observed in inside-out cytoplasmic vesicles. The modification was blocked by treatment with a membrane-impermeable thiol reagent, and it was concluded that the residue was located on the cytosolic side. ␤S30C was also modified, but, according to their figures, to a much greater extent than ␤S2C. This is in contradiction to our results, where the reactivity of ␤S30C toward fluorescein maleimide was low compared with the very reactive ␤S2C mutant (data not shown). A possible explanation for their results is that a small fraction of the vesicles were right sideout, which allowed ␤S2C to react with both maleimidylpropionylbiocytin and the blocking reagent. This would also explain the apparently weak signal of ␤S2C compared with ␤S30C. MIANS labeling was performed at high concentrations of MIANS (1 mM) and N,N-dimethylformamide (2%) for 2 h at room temperature. In our hands, slightly milder conditions produced a high degree of nonspecificity and leakage. Thus, the suggested locations of ␤S2C and ␤S30C may have been based on experimental conditions that did not allow a clear distinction between the two sides of the membrane. By showing that dicyclohexylcarbodiimide labeled Glu-␤124 but not Glu-␤85, they located Glu-␤85 outside the membrane and Glu-␤124 within the membrane. However, the support for the location of Glu-␤85 does not appear strong since the resistance to modification could be due to steric effects and/or an unfavorable local environment. The location of Glu-␤124 within the membrane is not directly in disagreement with our model since helix 10 probably ends before the positively charged Lys-␤145 residue and a stretch of ϳ21 residues is needed to span the membrane.
The present topology model includes 13 helices in E. coli transhydrogenase compared with the previously suggested 10 or 12. The odd number of transmembrane helices in the ␤-subunit arises from the location of the residues in helix 6 that previously were suggested to be extramembranous. In addition to the experimental data presented in this study, it is noteworthy that helix 6 was strongly predicted as a transmembrane helix by all the prediction algorithms used, which indeed was also tentatively suggested by Bragg and co-workers (11) . The insertion of the ␤-subunit of E. coli transhydrogenase into the membrane is not further complicated by the occurrence of an uneven number of helices since the main determinants for insertion of bacterial membrane proteins seem to follow the positive inside rule (37) . Since the N terminus is uncharged, it is likely to insert into the membrane until the translocation is stopped by the charged cytosolic loop around residues 26 -31.
The odd number of helices raises some questions about the relation between mitochondrial (e.g. bovine, human, mouse, and C. elegans) and non-mitochondrial transhydrogenases. For the mitochondrial transhydrogenases, only an even number of helices is possible since both the N and C termini of the single polypeptide are located on the matrix side. In contrast, the non-mitochondrial transhydrogenases may well be composed of an uneven number since they are interrupted in the membrane domain. Thus, the suggested 13-helix model of E. coli transhydrogenase is not in itself contradictory to the location of the hydrophilic domains, but if the topology should be considered general, as suggested by the high sequence identity and the similar predictions, one helix has to be added or removed to agree with the mitochondrial transhydrogenases. As mentioned under "Results," the topology predictions of mitochondrial transhydrogenases indicated a transmembrane helix where the gap between the ␣-and ␤-subunits is located. Also, the newly developed algorithm DAS (38) predicted an extra transmembrane helix composed of those residues lacking in the non-mitochondrial transhydrogenases (data not shown). This transmembrane segment would be able to connect helices 4 and 6 in the E. coli model, yielding an even number of transmembrane segments. Fusion of the E. coli ␣-and ␤-subunits in which an additional stretch of residues identical to the bovine sequence was inserted gives a much more active enzyme than if the two subunits are fused directly to each other, 4 further indicating the need for an additional segment to connect the two ends on opposite sides of the membrane. Thus, including helix 5 as a way to connect the ␣-subunit with the ␤-subunit seems more reasonable than exclusion of any of the helices.
Determination of the boundaries of helix 9 suggests that His-␤91, the only essential conserved protonatable residue within the membrane domain, is located at a distance of seven to nine residues (Ϸ10 -14 Å) from the cytosol-membrane interface. The lack of other conserved charged residues within the membrane suggests a proton pathway built up of polar residues and/or water molecules with one major regulatory site (His-91) within the membrane core. Of interest in this context is that helices 13 and 14, which are the most conserved transmembrane helices, contain a large fraction of conserved polar residues. Proximity of helices 9, 13, and 14 has not yet been shown, but it seems likely that they together contribute to a putative proton pathway.
In conclusion, we have determined the membrane topology of E. coli transhydrogenase by modifying introduced cysteines. The membrane domain was found to be composed of 13 transmembrane ␣-helices (four in the ␣-subunit and nine in the ␤-subunit) in which the C terminus of the ␣-subunit and the N terminus of the ␤-subunit face the cytosolic and periplasmic sides, respectively. It is likely that the 13-helix model presented here, with an additional helix in the mitochondrial enzymes, can be applied to all membrane-bound transhydrogenases.
